Dr. Reddy's Laboratories Limited (RDY) Key Statistics & Financial Ratios

Dr. Reddy's Laboratories Limited (RDY) — Price $12.32 — Healthcare — Drug Manufacturers - Specialty & Generic — NYSE

Latest reported results:

Key statistics dashboard for Dr. Reddy's Laboratories Limited (RDY). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products.

Stock Data

Price$12.32
Market Cap$10.3B
Enterprise Value$1.07T
Beta0.30
ExchangeNYSE
CountryIN

Valuation Multiples

P/E Ratio30.47
Price / Book2.63
P/S3.04
EV/EBITDA16.00
EV/Sales3.22
EV/FCF72.56
P/FCF68.55
Earnings Yield3.29%
FCF Yield1.46%
Dividend Yield0.66%

Profitability

Gross Margin50.18%
EBIT Margin13.73%
EBITDA Margin20.13%
Operating Margin10.64%
Net Margin10.00%
Return on Equity8.88%
Return on Assets5.75%
Return on Invested Capital5.84%
Return on Capital Employed8.43%

Financial Health

Current Ratio1.90
Quick Ratio1.39
Cash Ratio0.07
Debt / Equity0.19
Debt / Assets12.51%
Net Debt / EBITDA0.91
Interest Coverage8.47

Per-Share Data

Revenue per share397.74
Book Value per share464.45
Cash per share97.79
FCF per share17.66
Tangible Book Value per share324.58
Dividend per share8.00

Related companies: BMRN · EHC · ELAN · ENSG · EXEL · NBIX · RVMD

Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic

More sections of RDY: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks